News
Verseon Presents Anticancer Drug Candidates Targeting Multidrug Resistant Cancers
Verseon presented new preclinical studies on its anticancer drug candidates at the American Association for Cancer Research annual meeting yesterday. The data show that Verseon’ s drug candidates are potent against a range of cancer cell lines, including those that exhibit multidrug resistance. While chemotherapy remains the first line of treatment...
Verseon presented new preclinical studies on its anticancer drug candidates at the American Association for Cancer Research annual meeting yesterday. The data show that Verseon’ s drug candidates are potent against a range of cancer cell lines, including those that exhibit multidrug resistance. While chemotherapy remains the first line of treatment...